Improving the UK's attractiveness for industry research, development & manufacturing
![Scientist looking at petri dish on the microscope platform](/media/ihpdbfzp/scientist-microscope-defocussed-2522x722-banner-webp60.webp?width=968&height=457&rnd=133046191110000000)
![Two scientists discussing are standing in a lab in front of a microscope on the bench.](/media/vdhng3oq/asian-scientists-580x405-webp60.webp?width=768&height=513&rnd=133256767433670000)
Clinical trials are an essential part of the research and development (R&D) of new medicines and vaccines, bringing benefits to patients, the NHS and the economy.
![View looking up at a scientist using a pipette](/media/pq3fnuvz/scientist-pipetting-580x405-webp75.webp?width=768&height=513&rnd=133256767430070000)
The UK biopharmaceutical industry has a long and proud record of high quality, reliable manufacturing of medicinal products The UK medicines industry is one of our leading manufacturing sectors, with exports worth £24 billion and generating a trade surplus of £4.9 billion in 2012.
![Three analysts look at the charts on a screen](/media/arpoapgw/three-people-analysing-871x581-webp60.webp?width=768&height=513&rnd=133256767438230000)
This is the science of developing new tools, standards and approaches to evaluate the efficacy, safety, quality and performance of medical products in order to assess benefit-risk and facilitate a sound and transparent regulatory decision-making.
![Scientist looking at petri dish on the microscope platform](/media/wauejrdp/scientist-microscope-930x930-webp60.webp?width=768&height=513&rnd=133256767434270000)
Drug safety (also known as pharmacovigilance), is the science of detection, assessment, understanding and prevention of side effects which allows us to understand more about the risks and benefits of a medicine.
![Close-up of hands typing on a laptop, with a microscope in the background, being reflected on the screen](/media/fnecefc3/laptop-fingers-detail-871x581-webp60.webp?width=768&height=513&rnd=133256767435230000)
The ABPI is committed to supporting the sector in bringing the latest advances in genomics technologies and treatments to patients, and genomics research to develop new drugs to treat disease.
![Woman at a meeting, sits smiling at the unseen delegates](/media/ubtnpoha/woman-smiling-meeting-871x581-webp60.webp?width=768&height=513&rnd=133256767437730000)
The ABPI's People-centred Research Hub features a collection of member case studies that promote industry best practices in diversity and inclusion, patient and public involvement, and research transparency.